Episode 84 – In the AI C-Suite with David Golan, CTO and Co-Founder of Viz.ai
Medical Device Success
MARCH 20, 2022
Reading time: 2 – 4 minutes. Then the FDA team had an “Aha!” moment! At first, the meeting didn’t start off that well. The FDA heard the term “artificial intelligence” and were immediately skeptical. Then the Viz.ai team hit the pause button and said this was about speed to treatment for stroke, not necessarily doing a better job interpreting images.
130 
Let's personalize your content